Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Heart patients may ditch blood thinners after one year, new study hopes to prove

NCT ID NCT07398001

First seen Feb 10, 2026 · Last updated May 23, 2026 · Updated 14 times

Summary

This study looks at whether people who had a heart procedure with a drug-coated balloon can safely stop taking antiplatelet medication (blood thinners) after 12 months. Researchers will compare those who stop versus those who continue, tracking heart events and bleeding risks. About 1,042 adults who have been event-free for a year after their procedure will participate.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PERCUTANEOUS CORONARY INTERVENTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Kangwon National University Hospital

    Chuncheon, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Korea University Ansan Hospital

    Ansan, South Korea

    Contact Email: •••••@•••••

  • Korea University Guro Hospital

    Seoul, South Korea

    Contact Email: •••••@•••••

  • Kosin University Hospital

    Pusan, South Korea

    Contact Email: •••••@•••••

  • Samsung Medical Center

    Seoul, South Korea

    Contact Email: •••••@•••••

  • Ulsan Medical Center

    Ulsan, South Korea

    Contact Email: •••••@•••••

  • Ulsan University Hospital

    Ulsan, South Korea

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.